Quantitative assessment of the effect of angiotensinogen gene polymorphisms on the risk of coronary heart disease

Circulation

Volumn 116, Issue 12, 2007, Pages 1356-1366

  Xu, Ming Qing ^a,b,c   Ye, Zheng ^e   Hu, Frank B ^c,d   He, Lin ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Angiotensinogen; Coronary disease; Genetics; Haplotypes; Linkage disequilibrium; Myocardial infarction; Risk factor

Indexed keywords

ANGIOTENSINOGEN;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC HETEROGENEITY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; AGED; ALLELES; ANGIOTENSINOGEN; CORONARY DISEASE; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; POINT MUTATION; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; PUBLICATION BIAS; RESEARCH DESIGN; RETROSPECTIVE STUDIES;

EID: 34548671460     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.728857     Document Type: Article

References (61)

1. Hsueh WA. Effect of the renin-angiotensin system in the vascular disease of type II diabetes mellitus. Am J Med. 1992;92:13S-19S.
2. Wang JG, Staessen JA. Genetic polymorphism in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease. Eur J Pharmacol. 2000;410:289-302.
3. Harrap SB. Cardiovascular disease and genetics of the renin-angiotensin system. Heart. 1996;76:13-17.
4. Carluccio M, Soccio M, De Caterina R. Aspects of gene polymorphisms in cardiovascular disease: the renin-angiotensin system. Eur J Clin Invest. 2001;31:476-478.
5. Ishigami T, Umemura S, Iwamoto T, Tamura K, Hibi K, Yamaguchi S, Nyuui N, Kimura K, Miyazaki N, Ishii M. Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis. Circulation. 1995;91:951-954.
6. Tiret L, Ricard S, Poirier O, Arveiler D, Cambou JP, Luc G, Evans A, Nicaud V, Cambien F. Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction: the ECTIM Study. J Hypertens. 1995;13:311-317.
7. Kamitani A, Rakugi H, Higaki J, Ohishi M, Shi SJ, Takami S, Nakata Y, Higashino Y, Fujii K, Mikami H, Miki T, Ogihara T. Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension. 1995;25:950-953.
8. Katsuya T, Koike G, Yee TW, Sharpe N, Jackson R, Norton R, Horiuchi M, Pratt RE, Dzau VJ, MacMahon S. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet. 1995;345:1600-1603.
9. Yamakawa-Kobayashi K, Arinami T, Hamaguchi H. Absence of association of angiotensinogen gene T235 allele with increased risk of coronary heart disease in Japanese. Lancet. 1995;346:515.
10. Ludwig EH, Borecki IB, Ellison RC, Folsom AR, Heiss G, Higgins M, Lalouel JM, Province MA, Rao DC. Associations between candidate loci angiotensin-converting enzyme and angiotensinogen with coronary heart disease and myocardial infarction: the NHLBI Family Heart Study. Ann Epidemiol. 1997;7:3-12.
11. Wenzel K, Blackburn A, Ernst M, Affeldt M, Hanke R, Baumann G, Felix SB, Kleber FX, Rohde K, Glaser C, Speer A. Relationship of polymorphisms in the renin-angiotensin system and in E-selectin of patients with early severe coronary heart disease. J Mol Med. 1997;75:57-61.
12. Ichihara S, Yokota M, Fujimura T, Kato S, Hirayama H, Tsunekawa A, Inagaki H, Takatsu F, Nakashima N, Yamada Y. Lack of association between variants of the angiotensinogen gene and the risk of coronary artery disease in middle-aged Japanese men. Am Heart J. 1997;134:260-265.
13. Ko YL, Ko YS, Wang SM, Chu PH, Teng MS, Cheng NJ, Chen WJ, Hsu TS, Kuo CT, Chiang CW, Lee YS. Angiotensinogen and angiotensin-I converting enzyme gene polymorphisms and the risk of coronary artery disease in Chinese. Hum Genet. 1997;100:210-214.
14. Chen D, Zhang M, Fan W, Shi H, Li Y, Chen Q, Zhang J, Gu X. A molecular variant of angiotensinogen gene is associated with myocardial infarction in Chinese [in Chinese]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 1998;15:133-135.
15. Sheu WH, Lee WJ, Jeng CY, Young MS, Ding YA, Chen YT. Angiotensinogen gene polymorphism is associated with insulin resistance in nondiabetic men with or without coronary heart disease. Am Heart J. 1998;136:125-131.
16. Frossard PM, Hill SH, Elshahat YI, Obineche EN, Bokhari AM, Lestringant GG, John A, Abdulle AM. Associations of angiotensinogen gene mutations with hypertension and myocardial infarction in a gulf population. Clin Genet. 1998;54:285-293.
17. Cong ND, Hamaguchi K, Saikawa T, Hara M, Sakata T. A polymorphism of angiotensinogen gene codon 174 and coronary artery disease in Japanese subjects. Am J Med Sci. 1998;316:339-344.
18. Winkelmann BR, Russ AP, Nauck M, Klein B, Bohm BO, Maier V, Zotz R, Matheis G, Wolf A, Wieland H, Gross W, Galton DJ, Marz W. Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease. Am Heart J. 1999;137:698-705.
19. Fernandez-Arcas N, Dieguez-Lucena JL, Munoz-Moran E, Ruiz-Galdon M, Espinosa-Caliani S, Aranda-Lara P, Martinez-Espigares S, Banderas-Donaire MJ, De Teresa-Galvan E, Reyes-Engel A. The genotype interactions of methylenetetrahydrofolate reductase and renin-angiotensin system genes are associated with myocardial infarction. Atherosclerosis. 1999;145:293-300.
20. Gardemann A, Stricker J, Humme J, Nguyen QD, Katz N, Philipp M, Tillmanns H, Hehrlein FW, Haberbosch W. Angiotensinogen T174M and M235T gene polymorphisms are associated with the extent of coronary atherosclerosis. Atherosclerosis. 1999;145:309-314.
21. Fomicheva EV, Gukova SP, Larionova-Vasina VI, Kovalev YR, Schwartz EI. Gene-gene interaction in the RAS system in the predisposition to myocardial infarction in elder population of St. Petersburg (Russia). Mol Genet Metab. 2000;69:76-80.
22. Reinhardt D, Sigusch HH, Vogt SF, Zeiss C, Farker K, Hoffmann A, Muller S. A common variant of the angiotensinogen gene and the risk of coronary artery disease in a German population. Pharmazie. 2000;55:69-71.
23. Fatini C, Abbate R, Pepe G, Battaglini B, Gensini F, Ruggiano G, Gensini GF, Guazzelli R. Searching for a better assessment of the individual coronary risk profile: the role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen gene polymorphisms. Eur Heart J. 2000;21:633-638.
24. Wierzbicki AS, Lambert-Hammill M, Lumb PJ, Crook MA. Renin-angiotensin system polymorphisms and coronary events in familial hypercholesterolemia. Hypertension. 2000;36:808-812.
25. Batalla A, Alvarez R, Reguero JR, Hevia S, Iglesias-Cubero G, Alvarez V, Cortina A, Gonzalez P, Celada MM, Medina A, Coto E. Synergistic effect between apolipoprotein E and angiotensinogen gene polymorphisms in the risk for early myocardial infarction. Clin Chem. 2000;46:1910-1915.
26. Spiridonova MG, Stepanov VA, Puzyrev VP, Kosiankova TV, Karpov RS. Association between polymorphism T174M of the angiotensinogen gene and coronary atherosclerosis in the Tomsk population. Mol Biol. 2001;35:11-14.
27. Olivieri O, Stranieri C, Girelli D, Pizzolo F, Grazioli S, Russo C, Pignatti PF, Corrocher R. Homozygosity for angiotensinogen 235T variant increases the risk of myocardial infarction in patients with multi-vessel coronary artery disease. J Hypertens. 2001;19:879-884.
28. Rodriguez-Perez JC, Rodriguez-Esparragon F, Hernandez-Perera O, Anabitarte A, Losada A, Medina A, Hernandez E, Fiuza D, Avalos O, Yunis C, Ferrario CM. Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: the PROCAGENE study: Prospective Cardiac Gene. J Am Coll Cardiol. 2001;37:1536-1542.
29. Sethi AA, Tybjaerg-Hansen A, Gronholdt ML, Steffensen R, Schnohr P, Nordestgaard BG. Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease: six case-control studies from the Copenhagen City Heart Study. Ann Intern Med. 2001;134:941-954.
30. Fernandez-Arcas N, Dieguez-Lucena JL, Munoz-Moran E, Ruiz-Galdon M, Espinosa-Caliani S, Aranda-Lara P, Rius-Diaz F, Gaitan-Arroyo MJ, De Teresa-Galvan E, Reyes-Engel A. Both alleles of the M235T polymorphism of the angiotensinogen gene can be a risk factor for myocardial infarction. Clin Genet. 2001;60:52-57.
31. Xie Y, Zhang FM, Ma WZ, Yang D, Geng Q, Jia YP, Yang ZJ, Zhang JN. Association between gene polymorphism of renin-angiotensin system and coronary heart disease. Nanjing Yi Ke Da Xue Xue Bao. 2001;21:488-491.
32. Hernandez Ortega E, Medina Fernandez-Aceituno A, Rodriguez Esparragon FJ, Hernandez Perera O, Melian Nuez F, Delgado Espinosa A, Fiuza Perez D, Anabitarte Prieto A, Rodriguez Perez JC. The involvement of the renin-angiotensin system gene polymorphisms in coronary heart disease. Rev Esp Cardiol. 2002;55:92-99.
33. Liu Y, Jin W, Jiang ZW, Zhu HM, Sheng HH, Jin L, Sheng YY, Xu SJ, Huang W, Yu JD. Correlation between T174M and M235T polymorphism of angiotensinogen gene and coronary heart disease. J Diagn Concepts Pract. 2002;1:231-236.
34. Hooper WC, Dowling NF, Wenger NK, Dilley A, Ellingsen D, Evatt BL. Relationship of venous thromboembolism and myocardial infarction with the renin-angiotensin system in African-Americans. Am J Hematol. 2002;70:1-8.
35. Ermis C, Tsai MY, Hanson NQ, Akar N, Aras O. Angiotensin I converting enzyme, angiotensin II type 1 receptor and angiotensinogen polymorphisms and early myocardial infarction in Turkish population. Thromb Haemost. 2002;88:693-694.
36. Zhu TB, Xu W, Yang ZJ, Xie Y, Zhang FM, Jia YP, Cao KJ, Ma WZ. Association analysis of three polymorphism of renin-angiotensin system genes with coronary heart disease. Jiangsu Med J. 2002;28:745-746.
37. Ortlepp JR, Lauscher J, Janssens U, Minkenberg R, Hanrath P, Hoffmann R. Analysis of several hundred genetic polymorphisms may improve assessment of the individual genetic burden for coronary artery disease. Eur J Intern Med. 2002;13:485-492.
38. Babunova NB, Minushkina LO, Zateishchikov DA, Sidorenko BA, Nosikov VV. Association of the T174M and M235T polymorphisms of the angiotensinogen gene with coronary heart disease in ethnic Russians from Moscow. Mol Biol. 2003;37:52-55.
39. Buraczynska M, Pijanowski Z, Spasiewicz D, Nowicka T, Sodolski T, Widomska-Czekajska T, Ksiazek A. Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease. Kardiol Pol. 2003;58:1-9.
40. Gu WD, Zhu JH, Pan M, Yuan J, Gu YC, Cui ZC, Zai XC. Effects of angiotensinogen and apolipoprotein E gene polymorphisms on coronary heart disease. Nan Tong Yi Xue Yuan Xue Bao. 2003;23:394-395.
41. Nair KG, Shalia KK, Ashavaid TF, Dalal JJ. Coronary heart disease, hypertension, and angiotensinogen gene variants in Indian population. J Clin Lab Anal. 2003;17:141-146.
42. Bis JC, Smith NL, Psaty BM, Heckbert SR, Edwards KL, Lemaitre RN, Lumley T, Rosendaal FR. Angiotensinogen Met235Thr polymorphism, angiotensin-converting enzyme inhibitor therapy, and the risk of nonfatal stroke or myocardial infarction in hypertensive patients. Am J Hypertens. 2003;16:1011-1017.
43. Ranjith N, Pegoraro RJ, Rom L, Lanning PA, Naidoo DP. Renin-angiotensin system and associated gene polymorphisms in myocardial infarction in young South African Indians. Cardiovasc J S Afr. 2004;15:22-26.
44. Liu Y, Jin W, Jiang ZW, Zhang KX, Sheng HH, Jin L, Shen YY, Huang W, Yu JD. Six single nucleotide polymorphisms of angiotensin gene and essential hypertension [in Chinese]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004;21:116-119.
45. Zhu TN, Pan JQ, Shen ZJ, Zhao YQ, Shen T. Gene polymorphisms of renin-angiotensin system and coronary thrombosis disease. J Exp Hematol. 2004;12:674-679.
46. Liu Y, Jin Wei, Sheng HH, Jin L, Shen YY, Huang W, Yu JD. Association of single nucleotide polymorphisms in the 5′ upstream core promoter region of angiotensinogen gene with coronary heart disease. J Clin Cardiol. 2005;21:43-45.
47. Renner W, Nauck M, Winkelmann BR, Hoffmann MM, Scharnagl H, Mayer V, Boehm BO, Marz W, for the LURIC Study Team. Association of angiotensinogen haplotypes with angiotensinogen levels but not with blood pressure or coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study. J Mol Med. 2005;83:235-239.
48. Sekuri C, Cam FS, Ercan E, Tengiz I, Sagcan A, Eser E, Berdeli A, Akin M. Renin-angiotensin system gene polymorphisms and premature coronary heart disease. J Renin Angiotensin Aldosterone Syst. 2005;6:38-42.
49. Araujo MA, Goulart LR, Cordeiro ER, Gatti RR, Menezes BS, Lourenco C, Silva HD. Genotypic interactions of renin-angiotensin system genes in myocardial infarction. Int J Cardiol. 2005;103:27-32.
50. Ren J, Jia YP, Lv JY, Guo XH. Relationship between angiotensinogen gene M235T polymorphism and coronary heart disease. J Shanxi Med Univ. 2005;36:439-442.
51. Zhang AP, Ning SC, Li ZQ, Yi X. Polymorphism of angiotensinogen gene is associated with myocardial infarction in Chinese Han population. J Fourth Mil Med Univ. 2005;26:729-731.
52. Sethi AA, Nordestgaard BG, Gronholdt ML, Steffensen R, Jensen G, Tybjaerg-Hansen A. Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular disease. Hypertension. 2003;41:1202-1211.
53. Sethi AA, Nordestgaard GN, Tybjærg-Hansen AT. Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis. Arterioscler Thromb Vasc Biol. 2003;23:1269-1275.
54. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
55. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.
56. Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med. 1999;18:2693-2708.
57. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
58. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088 -1101.
59. Duval S, Tweedie R. A nonparametric "trim and fill" method of accounting for publication bias in meta-analysis. J Am Stat Assoc. 2000;95:89-98.
60. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet. 2003;33:177-182.
61. Morgan TM, Coffey CS, Krumholz HM. Overestimation of genetic risks owing to small sample sizes in cardiovascular studies. Clin Genet. 2003;64:7-17.